Pfizer stalls - Analysis - 14-08-2018

Pfizer's stock fell in the intraday levels as traders collected profits, while the stock gathered momentum to help it rise anew, as it also vented off overbought saturation in the RSI, marking a loss of 0.29% in the last session, or 0.12 points, amid positive pressure from the 50-day SMA, with the dominance of the main upward short-term trend. 

Therefore we expect the stock to return higher, provided the resistance of 41.12 was breached, targeting the next one at 43.29.